-
Product Insights
NewInfectious Diarrhea – Drugs In Development, 2024
Empower your strategies with our Infectious Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Infectious Diarrhea is a common gastrointestinal infection and the most common type of diarrhea. Diarrhea is defined as frequent bowel movements that are loose, watery, and associated with nausea, vomiting, and fatigue. Bacterial, viral, and protozoans are the common pathogens leading to infectious diarrhea. E. coli-associated infections are the most common bacteria while Entamoeba histolytica is a common parasite causing infectious diarrhea....
-
Product Insights
NewSensory Disorders – Drugs In Development, 2024
Empower your strategies with our Sensory Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Sensory Disorders or sensory processing disorders (SPD) is a neurological condition in children that affects the sensory stimuli of brain. It is also known as sensory integration dysfunction causing an increased or decreased sensitivity to light, smell, taste, sound, and touch. It is divided into 8 different types: proprioception, vestibular, interoception, and five senses. Hyposensitivity and hypersensitivity are observed in children. As...
-
Product Insights
NewPerennial Allergic Rhinitis – Drugs In Development, 2024
Empower your strategies with our Perennial Allergic Rhinitis – Drugs In Development, 2024 report and make more profitable business decisions. Perennial rhinitis is an inflammatory condition that causes nasal congestion and runny nose. It is of two types: perennial allergic rhinitis and non-allergic rhinitis. Dust mites, pet dander, and mold are the most common allergens respoinsible for allergic rhinitis. Physical examination, blood or skin testing, and CT scan can be used for diagnosis. Management includes allergen avoidance along with pharmacological treatment....
-
Product Insights
NewHeart Transplant Rejection – Drugs In Development, 2024
Empower your strategies with our Heart Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Heart transplantation is the therapy used to treat various heart diseases by replacing an injured or diseased heart with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplantation, the immune system may consider the transplanted heart as foreign and may work against it. Patients may hence develop complications and eventually reject the...
-
Product Insights
NewHyperalgesia – Drugs In Development, 2024
Empower your strategies with our Hyperalgesia – Drugs In Development, 2024 report and make more profitable business decisions. Hyperalgesia is an increase in pain response. Predisposing factors include long-term opioid usage, inflammation, damage to nociceptors, damage to peripheral nerves, and psychological disorders. Treatment includes antidepressants and non-steroidal anti-inflammatory drugs (NSAIDs). The Hyperalgesia drugs in development market research report provide comprehensive information on the therapeutics under development for Hyperalgesia, complete with analysis by stage of development, drug target, mechanism of action (MoA),...
-
Product Insights
NewLennox-Gastaut Syndrome – Drugs In Development, 2024
Empower your strategies with our Lennox-Gastaut Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Lennox-Gastaut syndrome (LGS) is a severe form of epilepsy that starts in early childhood, usually before the age of 4 years. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and abnormal brain electric activity. The seizures are frequent, occurring daily, and difficult to treat with anti-seizure medications. The most common seizure type is tonic seizure, which causes sudden stiffening...
-
Product Insights
NewHypertrophic Cardiomyopathy – Drugs In Development, 2024
Empower your strategies with our Hypertrophic Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the heart to pump blood. Symptoms include chest pain, especially during exercise; sensation of rapid, fluttering or pounding heartbeats; and heart murmur. Hypertrophic cardiomyopathy usually is inherited. Treatment includes beta blockers, calcium channel blockers, and blood thinners. The...
-
Product Insights
NewDiarrhea – Drugs In Development, 2024
Empower your strategies with our Diarrhea – Drugs In Development, 2024 report and make more profitable business decisions. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle. The Diarrhea drugs in development market research report...
-
Product Insights
NewErectile Dysfunction – Drugs In Development, 2024
Empower your strategies with our Erectile Dysfunction – Drugs In Development, 2024 report and make more profitable business decisions. Erectile dysfunction (ED) is the inability of a man to have an erection hard enough to have sexual intercourse. It is also known as impotence. The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use, and medications including antidepressants, antihistamines, and medications to treat high blood pressure, pain, or prostate cancer. The Erectile Dysfunction drugs in development market research report...
-
Product Insights
NewPeanut Allergy – Drugs In Development, 2024
Empower your strategies with our Peanut Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions such as hives, redness or swelling; itching or tingling in or around the mouth and throat; digestive problems, such as diarrhea, stomach cramps, nausea or vomiting; tightening of...